# To Assess the Prevalence, Management Practices, and Clinical Outcomes Associated With Hyperglycemia Among Hospitalized Patients, With a Particular Focus on the Interplay Between Metabolic Biomarkers, Nutritional Status, and Body Composition

> **NCT07626775** · — · COMPLETED · sponsor: **Medanta, The Medicity, India** · enrollment: 362 (actual)

## Conditions studied

- Diabete Mellitus
- Diabete Type 2
- Hyperglycaemia (Diabetic)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07626775
- **Lead sponsor:** Medanta, The Medicity, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07626775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07626775, "To Assess the Prevalence, Management Practices, and Clinical Outcomes Associated With Hyperglycemia Among Hospitalized Patients, With a Particular Focus on the Interplay Between Metabolic Biomarkers, Nutritional Status, and Body Composition". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07626775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*